Entry Detail



General Information

Database ID:TRD03582
Confidence:High
Contents:>> tsRNA Information
>> tsRNA Association Statistics
>> Disease Information
>> Disease Association Statistics
>> Evidence Support
>> Reference



tsRNA Information

tsRNA Name:tRF-Leu-CAA-004
tsRNA Type:tRF-5
Amino acid and Anticodon:LeuCAA
Sequence:GTCAGGATGGCCGAGT
Related Target:CYP2S1; CYP2C68; CYP2S2
Predicted Target:GSTT2B//GSTT2//AHRR//C6orf201//SEC13//TENM4//HRH4//HKDC1//COL11A1//LYL1
External Links:
MINTbase ID:tRF-16-SP5830E
tRFdb ID:N/A

[1] gtRNAdb_ID:tRNA-Leu-CAA-3-1
Anticodon:LeuCAA
tRNA_number:trna141
Chromosome:6
Strand:-
Coordinate:Start Site(bp): 27570439        End Site(bp): 27570454

[2] gtRNAdb_ID:tRNA-Leu-CAA-2-1
Anticodon:LeuCAA
tRNA_number:trna140
Chromosome:6
Strand:-
Coordinate:Start Site(bp): 27573509        End Site(bp): 27573524

[3] gtRNAdb_ID:tRNA-Leu-CAA-1-1
Anticodon:LeuCAA
tRNA_number:trna100
Chromosome:6
Strand:-
Coordinate:Start Site(bp): 28864090        End Site(bp): 28864105

[4] gtRNAdb_ID:tRNA-Leu-CAA-1-2
Anticodon:LeuCAA
tRNA_number:trna74
Chromosome:6
Strand:+
Coordinate:Start Site(bp): 28908830        End Site(bp): 28908845

[5] gtRNAdb_ID:tRNA-Leu-CAA-4-1
Anticodon:LeuCAA
tRNA_number:trna58
Chromosome:1
Strand:+
Coordinate:Start Site(bp): 249168054        End Site(bp): 249168069



tsRNA Association Statistics

Total Associated Disease Number:5
More Information
Network:
(Display the first 15 nodes)



Disease Information

 MeSHDisease Ontology
Disease ID:D000544DOID:10652
Disease Name:Alzheimer DiseaseAlzheimer's disease
Category:MeSHDisease Ontology
Type:Nervous System Diseases//Mental Disordersdisease of anatomical entity
Define:A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)A tauopathy that is characterized by memory lapses, confusion, emotional instability and progressive loss of mental ability and results in progressive memory loss, impaired thinking, disorientation, and changes in personality and mood starting and leads in advanced cases to a profound decline in cognitive and physical functioning and is marked histologically by the degeneration of brain neurons especially in the cerebral cortex and by the presence of neurofibrillary tangles and plaques containing beta-amyloid.
Alias:Acute Confusional Senile Dementia//Alzheimer Dementia//Alzheimer Disease, Early Onset//Alzheimer Disease, Late Onset//Alzheimer Sclerosis//Alzheimer Syndrome//Alzheimer Type Senile Dementia//Alzheimer's Disease//Alzheimer's Disease, Focal Onset//Alzheimer's Diseases//Alzheimer-Type Dementia (ATD)//Dementia, Alzheimer Type//Dementia, Presenile//Dementia, Primary Senile Degenerative//Dementia, Senile//Early Onset Alzheimer Disease//Familial Alzheimer Disease (FAD)//Focal Onset Alzheimer's Disease//Late Onset Alzheimer Disease//Presenile Alzheimer Dementia//Primary Senile Degenerative Dementia//Senile Dementia, Acute Confusional//Senile Dementia, Alzheimer TypeAlzheimer disease//Alzheimers dementia



Disease Association Statistics

Total Associated tsRNA Number:151
More Information
Network:
(Display the first 15 nodes)



Evidence Support

Strong Evidence:RT-PCR
Weak Evidence:High-throughput sequencing



Reference

[1] PubMed ID:34734009
Disease Name:Alzheimer Disease
Tissue:APP/PS1 Transgenic Mice
Dysfunction Pattern:Down-Regulation
Validated Method:RT-PCR//High-throughput sequencing
Description:Expression of tiRNA and tRF in APP/PS2 transgenic mice and the change of related proteins expression.
Comparision:Transgenosis VS Control
Mechanism:The APP expression and presenilin mutation in APP/PS1 mice could cause tiRNA and tRFs expression change. Among the differentially expressed tiRNA and tRFs, we found some tRFs took part in the voltage-gated calcium channel γ3 subunit expression and regulation, influencing the neuron calcium homeostasis. Moreover, we also found the tRFs may participate in the regulation of retinol metabolism. Our findings suggest that the dysregulated tiRNA and tRFs may be beneficially exploited as potential diagnostic biomarkers and/or therapeutic targets of AD.